Ziralimumab Biosimilar Monoclonal Antibody (CD147) for Research

Cat No.: GMP-Bios-INN-1059

Anti-BSG therapeutic antibody (Pre-made Ziralimumab biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package Price(In USD)
GMP-Bios-INN-1059-1mg 1mg 618
GMP-Bios-INN-1059-10mg 10mg
GMP-Bios-INN-1059-100mg 100mg
GMP-Bios-INN-1059-xmg ≥100mg



Product Details

Products Name (INN Index) Pre-Made Ziralimumab Biosimilar, Whole Mab, Anti-Bsg Antibody: Anti-5F7/CD147/EMMPRIN/EMPRIN/HAb18G/OK/TCSF therapeutic antibody
INN Name Ziralimumab
TargetBSG
FormatWhole mAb
Derivationhuman
Species Reactivityhuman
CH1 IsotypeIgM - nd
VD LCIgM - nd
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesAbgenix (Fremont CA USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0